Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in previously untreated mantle cell lymphoma.
Dr. Tycel Phillips
Advertisement
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Articles by Dr. Tycel Phillips
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
FDA Accepts Application for Padcev Plus Keytruda For Some With Bladder Cancer
2
Breast Cancer Awareness Versus ‘It Cannot Be’
3
Five-Time Survivor Reflects on Bladder Cancer: ‘There’s Always Hope’
4
Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer
5
